Zellweger syndrome, also referred to as cerebrohepatorenal syndrome, is a rare autosomal recessive disease representing the most severe form of the peroxisomal biogenesis disorders. Neuroanatomical sequelae include impaired neuronal migration, diffuse hypomyelination, and sensorineural degeneration. Due to the rare and severe nature of this disorder, early mortality, and comorbidities that place the patient at risk for sedated imaging, high-resolution magnetic resonance imaging findings of Zellweger syndrome are scarce in the literature. Presented here is a case of this rare disease imaged at 3.0 Tesla.
Introduction
Peroxisomes are cellular organelles responsible for the oxidative catabolism of very long chain fatty acids, the decomposition of hydrogen peroxide, and the biosynthesis of phospholipid molecules, which serve as the precursors to myelin production in the central nervous system. Mutations in peroxisome biogenesis factor (PEX) genes can result in a spectrum of diseases, including the Zellweger spectrum of peroxisome biogenesis disorders. The spectrum includes Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease, with Zellweger syndrome representing the most severe end of the spectrum. Patients with Zellweger syndrome, also known as cerebrohepatorenal syndrome, typically do not survive beyond the first year of life. 1 Since there are respiratory complications that result in greater sedationrelated risks, high-resolution depictions of magnetic resonance imaging (MRI) findings in this disorder remain scarce in the literature.
We present a case of an affected infant who was subsequently diagnosed with Zellweger syndrome via genetic testing after findings on a brain MRI suggested this disorder.
Case report
A retrospective chart review showed that the male child was born at 39 weeks' gestation by spontaneous vaginal delivery at an outside hospital. APGAR scores were 3 and 8 at one and five minutes, respectively. He was directly admitted to the neonatal intensive care unit (NICU) due to respiratory depression and hypotonia. While in the NICU, he was diagnosed with liver dysfunction, polycystic kidneys, patent ductus arteriosus, and an abnormality of the pulmonary arterial system. The patient exhibited facial dysmorphia, including mild hypertelorism, depressed nasal bridge with upturned nasal tip, long philtrum, thin lips, and low-set posteriorly rotated ears.
At the age of eight weeks, the infant was transferred to our facility as a result of ongoing seizures and failure to thrive. An MRI of the brain was ordered, and this was performed on a 3.0 Tesla Phillips Ingenia magnet. Pertinent findings included bilateral frontoparietal pachygyria (Figure 1 ), caudothalamic germinolytic cysts ( Figure 1 ), and bilateral perisylvian polymicrogyria ( Figure 2 ). The young age of the patient precluded the ability to assess the myelination pattern.
During the admission, the medical genetics team was consulted, and the appropriate genetic and metabolic testing was performed. Serum levels of very long chain and branched chain fatty acids as determined by gas chromatography were elevated, consistent with a defect in peroxisomal fatty acid oxidation. Urine testing using fast atom bombardment ionization mass spectroscopy showed elevated levels of long-chain bile acid intermediates, and urine testing by electron capture negative ion mass-fragmentography demonstrated increased levels of urine pipecolate. Genetic sequencing revealed two mutations in the PEX6 gene, one of the most common sources of the Zellweger spectrum phenotype. 2 The patient eventually expired at the age of eight months.
Discussion
Zellweger syndrome is named after Hans-Ulrich Zellweger 3 who first described the disease. It is the most common peroxisomal disorder presenting in early infancy, and is seen in 1 in 50,000-100,000 live births. 4 The inheritance pattern is autosomal recessive.
The diseases of the Zellweger spectrum comprise group A of the peroxisomal biogenesis disorders 5 in which the peroxisomes appear abnormal and exhibit generalized loss of function, with Zellweger syndrome designated as the prototype disease in this family of disorders. 6 Group B refers to diseases in which peroxisomes are present with loss of multiple peroxisome functions such as that seen in rhizomelic chondrodysplasia punctata and Zellweger-like syndrome. Group C includes a myriad of at least 10 disorders in which peroxisomes are present with only a single loss of function, the most common of which is X-linked adrenoleukodystrophy. An entity sometimes referred to as pseudo-Zellweger syndrome, peroxisomal thiolase deficiency, is also a group C disorder. 5 Peroxisomal disorders that present in the neonatal period generally result in hypotonia, seizures, and skeletal abnormalities, including facial dysmorphism. Optic-nerve hypoplasia is also common, as are liver abnormalities, leading to jaundice. Abnormal formation of facial structures, including a depressed nasal bridge, high forehead, and deformed ears, are classic for this disorder 7 and were apparent in this patient.
The laboratory diagnosis of Zellweger syndrome relies on abnormally elevated levels of very long chain fatty acids (VLCFA), particularly those with a carbon chain of at least 26 atoms. These molecules are present in great abundance due to the inability to catabolize these substrates in the cell. As such, the ratio of 26carbon fatty acids to 22-carbon fatty acids in the plasma is a marker for peroxisomal disorders, though VLCFA are normal in Refsum disease and rhizomelic chondrodysplasia punctata. The accumulation of VLCFA within the cell membranes of neurons results in functional loss and eventual cell demise. 8 Animal models suggest that neuronal migration abnormalities may be due to glutamate receptor dysfunction. 9 Migrational anomalies are typically not associated with X-linked adrenoleukodystropy or infantile or classic Refsum disease, which means that high-resolution imaging of the brain serves as a key component of the diagnostic workup. Further evidence suggests that MRI findings indicative of a leukodystrophy in the setting of inconclusive peroxisomal blood testing may prompt more sensitive assays such as fibroblast immunofluorescence microscopy. 10 There is no cure for Zellweger syndrome, but one investigative approach is to supplement the diet with docosahexaenoic acid. In one study, 11 MRI evaluation showed improved myelination in 9/20 patients. In our patient, however, the use of dietary supplementation was discouraged by a consulting specialist due to the possibility of bone-marrow suppression. 
Conclusion
Early neurologic imaging findings of peroxisomal disorders such as the Zellweger spectrum may be subtle, and MRI may provide critical information that prompts a more specific diagnostic approach to the patient. As such, the increased sensitivity of 3.0 Tesla MRI plays a crucial role in the workup of these children.
